Catalog No.: PC-72416Not For Human Use, Lab Use Only.
EMI1 (EGFR MaMTH Inhibitor 1, ChemBridge 5213777) is an EGFR ex19del/T790M/C797S and EGFR L858R/T790M/C797S activating mutant inhibitor, inhibits viability of PC9 EGFR ex19del/T790M/C797S with EC50 of 115 nM, potently reducing the interaction of EGFR triple mutant with Shc1 in MaMTH-DS assays.
EMI1 (EGFR MaMTH Inhibitor 1, ChemBridge 5213777) is an EGFR ex19del/T790M/C797S and EGFR L858R/T790M/C797S activating mutant inhibitor, inhibits viability of PC9 EGFR ex19del/T790M/C797S with EC50 of 115 nM, potently reducing the interaction of EGFR triple mutant with Shc1 in MaMTH-DS assays.
EMI1 binds to Coatomer Protein Complex Beta 2 (COPB2) with KD of 3.98 uM.
EMI1 strongly inhibit the viability and increase the caspase 3/7 activity of PC9 EGFR ex19del/T790M/C797S triple mutant cells than non-cancerous human bronchial epithelial (HBE) cells.
EMI1 inhibited PC9 EGFR ex19del/T790M/C797S organoid growth with EC50 of 131 nM.
EMI1 exerts an inhibitory effect on the uptake and distribution of activated, mutant EGFR receptor in early endosomes.
EMI1 attenuates RTK expression and signalling and alters the electrophoretic mobility of Coatomer Protein Complex Beta 2 (COPB2) in lung cancer cells.
